Sorcero Secures $42.5M Series B Funding for AI Platform Serving Global Pharma Companies

Sorcero, an AI-powered intelligence platform for life sciences, secures $42.5 million in Series B financing led by NewSpring Growth, with additional investments from Leawood Venture Capital and Blu Ventures. The funding enables Sorcero to expand across medical affairs, safety, scientific communications, and medical device segments globally.